| Aug 5 |
Genmab stock slides 7% as BioNTech ends acasunlimab collaboration
|
| Aug 5 |
BioNTech SE (BNTX) Q2 2024 Earnings Call Transcript
|
| Aug 5 |
BioNTech exits PD-L1 development with Genmab as Q2 revenues drop
|
| Aug 5 |
BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls
|
| Aug 5 |
BioNTech Second-Quarter Loss Widens as COVID-19 Vaccine Demand Falls
|
| Aug 5 |
BioNTech SE 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 5 |
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
|
| Aug 5 |
BioNTech counts on shift to cancer drugs after second quarter losses quadruple
|
| Aug 5 |
BioNTech GAAP EPS of -€3.36, revenue of €128.7M
|
| Aug 5 |
BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
|
